“President Trump personally instructed top officials at the Centers for Disease Control, the Food and Drug Administration and the National Institutes of Health to focus on the two (anti-malaria) drugs as potential therapies,” per Reuters’ sources. https://t.co/g1V0HG6Jau— southpaw (@nycsouthpaw) April 5, 2020